• Dra. Katia Pagnano, Hemocentro - Universidade de Campinas (UNICAMP), Campinas, SP (Brazil)
• Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brazil)
• Profa Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brazil)

COVID-19 vaccines and CML  - perspectives from Brazil
(in Portuguese) incl. Q&A Session

Program:

Conversas sobre vacinas para COVID-19 e leucemia mieloide crônica em português

Junte-se a nós nesse evento, onde especialistas discutirão aspectos importantes das vacinas para COVID-19 e esclarecerão dúvidas sobre as vacinas para COVID-19 em pacientes com LMC.

1. COVID-19 e leucemia mieloide crônica - experiência brasileira e latino-americana:
   Dra. Katia Pagnano, Hemocentro - Universidade Estadual de Campinas (UNICAMP), Campinas, SP (Brasil)
2. Visão geral sobre as vacinas contra COVID-19 no Brasil - experiência em pacientes hematológicos e LMC: Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brasil)
3. Vacinas para COVID e transplante de medula óssea na LMC:
   Profa. Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brasil)
4. Q&A (perguntas e respostas)

• Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
• Dr Ana Carolina Toreli, Hospital Brigadeiro, São Paulo (Brazil)
• Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de
  Sigueira Cavalcanti, Rio de Janeiro (Brazil)                                                                     

CML management during the COVID-19 pandemic – perspectives from Brazil
(in Portuguese) incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

• Situação atual da COVID no Brasil
• O que sabemos sobre LMC e COVID
  
  
• Recomendações para o tratamento da LMC durante a pandemia:
  tratamento do paciente recém diagnosticado, pacientes em tratamento
  - necessidade de ajuste de dose/troca/interrupção,
  considerações sobre TFR durante a pandemia
  
  
• Recomendações para o tratamento do paciente com LMC e COVID:
  no recém diagnosticado, necessidade de ajuste de dose/troca/interrupção
  durante a COVID, interações dos TKI com outras drogas
• Perspectivas futuras: vacinas, tratamentos

• Dr Jiang Qian, Peking University People’s Hospital, Beijing (China)
• Dr Xuelin Dou, Peking University People’s Hospital, Beijing (China)

CML management during the COVID-19 pandemic
– perspectives from China (in Mandarin)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

• Patients with hematological malignancies during the SARS-CoV-2 pandemic
  
  
• Patients with chronic myeloid leukemia during the SARS-CoV-2 pandemic
  
  
• CML treatment recommendations for patients without COVID-19 during the SARS-CoV-2 pandemic

• Dr Elza Lomaia, Almazov National Medical Research Centre, St. Petersburg
  (Russian Federation)
• Dr Jurii Osipov, Almazov National Medical Research Centre, St. Petersburg
  (Russian Federation)
• Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow
  (Russian Federation)

CML management during the COVID-19 pandemic
– perspectives from Russia
(in Russian) incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

• CML treatment recommendations for patients without COVID-19
  including therapy initiation / therapy switch / monitoring / new trials and drugs for CML

• The optimal strategy for prevention of COVID-19 and management
  of COVID-19 patients

• Recommendations for treating patients with CML and COVID-19
  including therapy initiation / therapy switch / therapy stopping /
  any interaction with COVID-19 treatment / TFR

• Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)
• Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires, Argentina
• Dr Virginia Abello Polo, Clínica del Country / Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia)

CML management during the COVID-19 pandemic
– perspectives from Argentina and Colombia
(in Spanish) incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

• Situación actual en Argentina
• Situación actual en Colombia.
• Recomendaciones para el tratamiento de los pacientes con LMC y COVID-19
  • Decisiones de tratamiento
  • Aspectos sobre el monitorio
  • Evento adverso
  • Discontinuación de tratamiento